<DOC>
	<DOCNO>NCT01353274</DOCNO>
	<brief_summary>Investigation safety efficacy daily use Micamlo Combination Tablets AP patient Hypertension</brief_summary>
	<brief_title>Safety Efficacy Daily Use MicamloÂ® Combination Tablets AP Patients With Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Inclusion criterion : Male Female patient hypertension receive MICAMLO Combination Tablets AP start study Exclusion criterion : Patients history hypersensitivity ingredient Micamlo Combination Tablets AP dihydropyridine derivative Pregnant woman possibly pregnant woman Patients extremely poor bile secretion patient serious hepatic disorder</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>